ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
17 announcements with these filters
Dev Labtech Venture Ltd reported revenue from operations of ₹155.2 Cr (+215.4% YoY) and net profit of ₹9 Cr (+2900.0% YoY) for H1 FY27.
Dev Labtech Venture approved issuance of up to 1.37 crore convertible warrants at Rs.13 each to promoters and non-promoters on preferential basis. The issue aggregates Rs.17.81 Crore for cash.
Dev Labtech's shareholders approved raising authorised share capital from ₹25 Crore to ₹31 Crore at an EGM on 5 November 2026. The Memorandum capital clause is amended.
Dev Labtech Venture's EGM passed an authorised capital increase and a convertible warrant issue, both with 100% votes in favour. Promoters did not vote on the warrants.
Dev Labtech Venture held an EGM on 5 November 2026 and filed voting results. Resolution 2, approving convertible warrants on a preferential basis, passed with 100% votes in favour.
Dev Labtech Venture's EGM considered an authorised capital increase and preferential convertible warrants. Voting results follow later; no issue amount or price is stated.
Dev Labtech Venture schedules a board meeting on 6 November 2026 to approve half-year standalone and consolidated results. The trading window stays closed until 48 hours after results are declared.
Dev Labtech Venture Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Dev Labtech Venture will hold an EGM to approve the preferential issue of 1.37 crore convertible warrants, raising ₹17.81 Crore.
Dev Labtech Venture Limited announced an increase in authorized share capital from 50 million to 62 million equity shares, each with a face value of Rs 5.
Dev Labtech Venture approved the preferential issue of 1.37 crore convertible warrants aggregating ₹17.81 crore. The company also increased its authorised share capital for future expansion.
Dev Labtech Venture Ltd has scheduled a board meeting for October 7, 2026, to discuss raising funds via preferential allotment and increasing authorized share capital.
Dev Labtech Venture Limited held its 33rd Annual General Meeting on September 26, 2026. Members considered the adoption of financial statements, director appointment, and related party transactions.
Dev Labtech executed a ₹2.10 Cr working capital facility with HDFC Bank at 8.9% floating interest. The 12-month overdraft is secured against residential and commercial property.
Dev Labtech Venture Limited has issued letters to unregistered shareholders providing a weblink to access the 33rd AGM Notice and Annual Report for FY 2025-26.
Dev Labtech Venture Limited has filed its 33rd Annual Report for the financial year 2025-26 in compliance with SEBI Listing Regulations.
Dev Labtech Venture held a board meeting on August 27, 2026, approving the Directors' Report and scheduling the 33rd Annual General Meeting for September 26, 2026.